Skip to main content
Pediatrics logoLink to Pediatrics
. 2013 May;131(5):968–980. doi: 10.1542/peds.2012-2610

Common Syndromes of Orthostatic Intolerance

Julian M Stewart 1,
PMCID: PMC3639459  PMID: 23569093

Abstract

The autonomic nervous system, adequate blood volume, and intact skeletal and respiratory muscle pumps are essential components for rapid cardiovascular adjustments to upright posture (orthostasis). Patients lacking sufficient blood volume or having defective sympathetic adrenergic vasoconstriction develop orthostatic hypotension (OH), prohibiting effective upright activities. OH is one form of orthostatic intolerance (OI) defined by signs, such as hypotension, and symptoms, such as lightheadedness, that occur when upright and are relieved by recumbence. Mild OI is commonly experienced during intercurrent illnesses and when standing up rapidly. The latter is denoted “initial OH” and represents a normal cardiovascular adjustment to the blood volume shifts during standing. Some people experience episodic acute OI, such as postural vasovagal syncope (fainting), or chronic OI, such as postural tachycardia syndrome, which can significantly reduce quality of life. The lifetime incidence of ≥1 fainting episodes is ∼40%. For the most part, these episodes are benign and self-limited, although frequent syncope episodes can be debilitating, and injury may occur from sudden falls. In this article, mechanisms for OI having components of adrenergic hypofunction, adrenergic hyperfunction, hyperpnea, and regional blood volume redistribution are discussed. Therapeutic strategies to cope with OI are proposed.

Keywords: syncope, postural tachycardia syndrome, orthostatic hypotension, autonomic nervous system, hypocapnia


Upright posture (orthostasis) stresses regulatory capabilities of the circulatory system1 including an intact heart, intact vascular structure and function, adequate blood volume, and intact physical pumps comprising the skeletal muscle pump (leg muscles that compress leg veins) and the respiratory-abdominal muscle pump, which enhances systemic venous return during respiration.2,3 Upright stance causes dependent venous pooling. Muscle pumps propel blood back to the heart when upright and during exercise.2 Enabling the skeletal muscle pump forms an important class of physical countermeasures against orthostatic intolerance (OI).4,5

Apart from muscle pumps, rapid orthostatic circulatory adjustments depend on the autonomic nervous system (ANS) comprising sympathetic and parasympathetic arms forming a framework for heart rate (HR) and blood pressure (BP) stability. The myogenic response6 and flow-dependent mechanisms7 primarily act to ensure tissue-level perfusion and autoregulation. The sympathetic arm acts through its primary vascular neurotransmitter norepinephrine8 and cotransmitters neuropeptide Y and ATP9 to produce arterial vasoconstriction and venoconstriction, increase cardiac contractility and HR, stimulate adrenal epinephrine release, and control the neuroendocrine and vascular function of the kidney and long-term BP control. The parasympathetic arm, via vagal nerve efferents, contributes most to HR changes at rates less than the intrinsic rate.10 Recent work indicates strong vagal influences on sympathoexcitation11 and important effects on nitrergic (nitric oxide containing nerves) vasodilation of the large cerebral arteries.12 Endocrine and local systems (eg, nitric oxide, local angiotensin) impact the vascular milieu but are slower to develop, often acting to modulate or set tonic activity of the ANS.9 Autonomic control of HR and BP during orthostasis is provided by subsystems designated “baroreflexes” (pressure reflexes), loosely grouped as arterial and cardiopulmonary baroreflexes, which maintain BP under changing conditions such as orthostasis.13

The Normal Orthostatic Response and Initial Orthostatic Hypotension

When supine, blood volume within the central thoracic vasculature is relatively large, although a disproportionate amount (25%–30%) of blood is stored within the splanchnic venous reservoir.14 Standing transfers >500 mL of central blood caudally, further increasing the volume of the splanchnic pool and filling veins of the lower extremites.15 An initial period of instability follows, denoted initial orthostatic hypotension16 (IOH, Fig 1) during which BP can decrease by ≥30%, reaching its nadir at 10 to 20 seconds after standing. Reflex tachycardia occurs. BP is restored within 30 to 60 seconds. IOH results from the normal delay of arterial baroreflex detection and response to gravitational blood volume redistribution. Lightheadedness, postural instability, and occasionally brief loss of consciousness occur and are relieved by recumbency, making IOH a form of OI. Thereafter, HR decreases but remains elevated compared with supine, and BP is restored by arterial vasoconstriction, elastic recoil of venous blood in dependent veins, and active venoconstriction in splanchnic veins.17

FIGURE 1.

FIGURE 1

IOH upon standing. There is a short-lived decrease in BP (upper panel) and increase in HR (lower panel). The fall in BP is resolved within ∼20 seconds. The patient experienced transient lightheadedness.

After IOH recovery, upright blood volume slowly decreases because of microvascular filtration.18 Decreased venous return decreases central blood volume and cardiac output (CO) by 20% despite baroreflex mediated vasoconstriction, increased cardiac contractility, and increased HR. Cerebral blood flow velocity (CBFv) decreases by 3% to 12% partly because of reduced cerebral perfusion pressure by 20 mm Hg.19 Cerebral autoregulation (unchanged cerebral blood flow [CBF] despite changing BP) is blunted during orthostasis. Unless the muscle pump is evoked, standing still places us at risk for decreased CO and CBF.

OI

Orthostasis means standing up. OI can be defined by the inability to tolerate the upright posture because of signs and symptoms relieved by lying down.20 If symptoms initiate while supine, then there is no OI. Transient OI is commonly experienced during dehydration or infectious disease. Typical signs and symptoms include loss of consciousness or lesser cognitive deficits (memory loss, decreased reasoning and concentration), visual difficulties, lightheadedness, headache, fatigue, either increases (hypertension) or decreases (hypotension) of BP, weakness, nausea and abdominal pain, sweating, tremulousness, and exercise intolerance.21 Unless one is in harm’s way (eg, standing on a cliff), OI is not lethal. Some OI findings, such as nausea and sweating, pertain directly to autonomic activation. However, loss of consciousness, severe lightheadedness, and neurocognitive loss relate to central nervous system (CNS) dysfunction and oblige recumbence. CNS symptoms are produced by altered brain blood flow perhaps involving the brainstem. CBFv is shown in Fig 2 for 2 common forms of OI, vasovagal syncope (VVS) and postural tachycardia syndrome (POTS).

FIGURE 2.

FIGURE 2

Decreased CBFv measured by transcranial Doppler ultrasound occurs during a VVS, (shown in the upper panel) and in POTS (shown in the bottom panel). During VVS, CBF declines gradually at first and then more abruptly as the patient acutely loses consciousness. In POTS, CBF is fairly uniformly reduced; there is no loss of consciousness, although lightheadedness is typical.

Cerebral autoregulation may be compromised,22 as in POTS23 and VVS.24 CBFv may be reduced by hyperventilation and hypocapnic cerebral vasoconstriction. Involuntary postural hyperventilation, mostly hyperpnea, is observed in all VVS patients25 and 50% of POTS patients in my laboratory.26 Trigeminal, sympathetic, or parasympathetic nerve activity may also affect orthostatic CBF.27

Orthostatic Stress Testing and Tools to Study OI

Perhaps the best “test” is medical history, which can often diagnose OI based on symptoms relieved by recumbence. Orthostatic stress tests supplement history by evoking OI in the laboratory. The predictive value of laboratory-induced OI for real-world OI is unclear, at least for syncope: in >40-year-old adults, tilt tests do not predict VVS.28 Controlled studies have not been performed in younger patients. There is no reference standard for orthostatic testing. Standing without movement may be the most physiologic orthostatic stress but is complicated by muscle pump activity.29 Therefore, tilt tables30 are used to restrict patient movement while passively placing them upright. A recent adult study of POTS31 compared the diagnostic accuracy of standing for 10 minutes with 60° upright tilt for ≥10 minutes. Results showed that standing after being supine for 1 hour was at least as good as 10-minute tilt; longer tilts introduced excessive numbers of false positives. Standing HR and BP measurements were taken at 1, 3, 5, and 10 minutes. Thus, standing tests for POTS requires previous supine rest. In our hands, >20 minutes is needed to reach fluid equilibrium. More dramatic results can be obtained by lower body negative pressure,32 which best simulates hemorrhage but duplicates many OI findings. A combination of lower body negative pressure with upright tilt can evoke OI (usually syncope) in everyone. Tests always include measurements of BP, HR, and heart rhythm and are supplemented in research laboratories by measurements of beat-to-beat CO, CBFv, regional blood flow, blood volume, sympathetic nerve activity, synaptic norepinephrine spillover,33 and vascular biopsy.34

Types of OH

IOH

Fulfills criteria for OI and has been previously discussed. Treatment options are shown in Table 1.

TABLE 1.

Treatment Options

Orthostatic syndrome Defect/pathophysiology Treatment
Initial OH Rapid redistribution of blood to dependent body Physical counter-maneuvers: sit down, isometric exercise (exercise pressor reflex)
Infrequently supportive medication such as midodrine or fludrocortisone
Neurogenic OH Systemically defective or absent adrenergic vasoconstriction; autonomic failure frequent parasympathetic dysfunction Physical counter-maneuvers: lie down, sit down, squat, clench buttocks, leg crossing, support garment
Droxidopa,118,119 salt and water loading, fludrocortisone, midodrine, atomoxetine + yohimbine; if secondary (eg, diabetes) treat underlying disorder
Rapid water ingestion palliation
Nonneurogenic OH Loss of blood volume, vasodilator drugs Correct problem
Neuropathic POTS Loss of regional vasoconstrictive ability Physical counter-maneuvers, salt and water loading, midodrine, Mestinon, exercise
Rapid water ingestion palliation
Hyperadrenergic POTS Adrenergic potentiation Physical counter-maneuvers
β-blockers, AT1RB (angiotensin-II type 1 receptor blocker), ivabradine? fludrocortisone, exercise
Postural VVA ? Loss of regional vasoconstrictive ability Physical counter-maneuvers
? Acute reversible baroreflex dysfunction Salt and water
Acute water ingestion
Selective serotonin reuptake inhibitor; Midodrine
Rapid water ingestion palliation

Orthostatic Hypotension

True orthostatic hypotension (OH) was defined by consensus in 2011 as sustained reduction of systolic BP >20 mm Hg or of diastolic BP >10 mm Hg within 3 minutes of standing or head-up tilt.35 OH is illustrated in Fig 3. A simple test for OH is to observe BP and HR once a minute during a 3-minute stand.

FIGURE 3.

FIGURE 3

NOH: mean arterial pressure (MAP, top panel) and HR ( bottom panel) are shown during a standing test. The BP begins to decrease immediately upon standing and continues to decrease until the patient is supine. HR increases by only a small amount despite hypotension.

Nonneurogenic OH is relatively common in the young. It can be caused by drugs or hypovolemia (eg, dehydration, hemorrhage). It is by far the most common form of OH in the young. There is no failure of autonomic function but rather incomplete ANS compensation for excessive nonautonomic stressors.

Neurogenic OH (NOH) signifies serious autonomic illness. It is identified with true autonomic vasoconstrictor failure due to the inadequate release of norepinephrine from sympathetic nerves.35 HR may not increase appropriately with standing. Treatment options are shown in Table 1. NOH is rare in young people but associated with diabetes, amyloidosis, primary autonomic failure and Parkinson’s disease in older patients.36 NOH may occur in up to 17% in adults >65 years old.37

POTS

POTS is defined by chronic day-to-day symptoms of OI plus excessive increase in HR when upright (Fig 4). Hypotension is not in the definition.38 Sinus rhythm is required. POTS is identified with chronic OI39: there must be daily symptoms, and the illness must be present for several months. HR normally increases with standing. Excessive tachycardia was defined in adults by a sustained increase >30 beats per minute or to a HR >120 beats per minute during a 10-minute tilt. Concurrent OI symptoms are necessary. Standardized standing tests are established in adults.31 Larger HR increments are observed in healthy young people; the HR increment for POTS has increased to >40 beats per minute in children and teens aged 8 to 19 years.40 The number of POTS patients within the United States was estimated at >500 000 in 1999.20 Current estimates are much higher. However, the actual prevalence of POTS is unknown.34

FIGURE 4.

FIGURE 4

A representative POTS patient’s data. HR (top panel) increases excessively without significant change in mean arterial pressure (MAP, bottom panel) change during a tilt test.

What Causes POTS?

POTS is caused by alterations of the autonomic nervous system, although mild to moderate all-cause hypovolemia mimics POTS.

Vagal Withdrawal and the Sinus Node

In some mildly ill individuals, POTS is related to loss of parasympathetic slowing of the heart with few peripheral circulatory abnormalities. Upright HRs rarely exceed 120 beats per minute. Often agents that increase cardiac parasympathetic activity such as β-blockers,41 cardiac glycosides,42 acetylcholinesterase inhibitors (pyridostigmine),43 or ivabradine44 (not US Food and Drug Administration approved) relieve symptoms.

Others may have excessive β-adrenergic sensitivity of the sinus node. This condition is denoted “inappropriate sinus tachycardia”45 and is regarded as distinct from POTS but less common. Supine HRs >100 beats per minute are observed, symptoms are less severe than in POTS, and β-blocker therapy can be efficacious.

Neuropathic POTS and Hyperadrenergic POTS

The remainder of patients are often partitioned among neuropathic POTS, in which partial dysautonomic adrenergic denervation occurs, and hyperadrenergic POTS, in which sympathetic overactivity prevails.

Neuropathic POTS

As originally described, decreased adrenergic vasoconstriction in the legs causes decreased norepinephrine spillover,46 vasodilation,47 and increased blood flow even supine.48 When upright, redistributive central hypovolemia caused by leg blood pooling leads to reflex tachycardia.48 In another neuropathic variant, decreased adrenergic vasoconstriction and redistribution of central blood to the splanchnic vasculature49 causes reflex tachycardia. Intense leg vasoconstriction produces acrocyanosis. Autonomic autoimmune neuropathy,50 presenting as POTS, causes similar reflex tachycardia. Central hypovolemia produces hyperpnea and hypocapnia in 50% of our patients.26 Treatment with vasoconstrictors (eg, midodrine) and pyridostigmine can help.

Hyperadrenergic POTS

The adrenergic synapse can be altered at presynaptic or postsynaptic levels. Presynaptic abnormalities include increased sympathetic nerve activity even when supine. Although this has been reported,38 the finding is not consistent.51

Increased synaptic norepinephrine is observed in the norepinephrine transporter (NET) deficiency heterozygote,52 and in more prevalent epigenetic NET downregulation33. Presynaptic and postsynaptic adrenergic activity may be enhanced by local chemical milieu, including angiotensin-II excess caused by angiotensin converting enzyme–253 deficit and nitric oxide deficiency, a hyperadrenergic variant with tachycardia, pallor, vasoconstriction, and absolute hypovolemia. Angiotensin (type 1) receptor blockers have shown benefit. β-blockers may also help.

Distinguishing Among POTS Variants: A Matter of Opinion

Distinguishing among POTS variants may be difficult for the pediatrician (and for the OI expert) despite apparent straightforward differences. Some would say that POTS with increased upright BP is hyperadrenergic; others would say that increased plasma catecholamines (or better, increased norepinephrine spillover) is required. Excessive orthostatic BP is a matter for consensus because both systolic and diastolic BP normally increase upon standing; how much is too much is unclear. As a heuristic, POTS patients with high supine HR, who are cool to touch and are pasty white in appearance when supine, often have hyperadrenergic POTS. Standing HR is elevated to the 130 to 180 range during quiet standing indicating hyperadrenergic drive; vagal withdrawal alone increases HR to the 100 to 120 range. Those with upright HR <120 beats per minute are more likely neuropathic. Recent (unpublished) work with sympathetic nerve recordings have demonstrated normal sympathetic activity when supine and supranormal activity when upright. This supports adrenergic enhancement (NET deficiency, angiotensin-II excess) in patients with hyperadrenergic POTS. Confusing matters further, neuropathic patients can have increased upright catecholamines even though spillover is decreased in the lower extremities.46

Gravitational Deconditioning—Caveat Bedrest!

One confounding and alarming issue is the tendency for POTS patients to bedrest. Prolonged bedrest emulates microgravity and has deleterious effects54 including OI,55 profound reductions in blood volume and cardiac size, redistribution of blood, osteoporosis, skeletal muscle pump atrophy, and more.56 Vasoconstriction is impaired.57 Bedrest causes a self-perpetuating state of OI, which can emulate or intensify POTS. It is paramount for POTS patient to leave bed and recondition. Well-structured exercise protocols are essential and must accommodate patients who start off bedrested.58 Reconditioning invariably improves patient well-being. Recent work supports the idea that POTS patients are also exercise deconditioned compared with matched volunteers.59 Although exercise deconditioning may or may not be causal in POTS, it is clear that exercise reconditioning is beneficial and should be advocated for all POTS patients.

What Are POTS Patients Like?

Quality of life can be severely compromised. A few features are common to all variants:

  • Females predominate 3:1. Onset is usually from menarche to menopause.

  • The onset often follows a flulike illness. Illness may occasionally represent a self-limited autoimmune disease.50 The role of immune and epigenetic factors remains ill defined.

  • Some patients have an insidious onset over years, sometimes with a past history of VVS.

  • Some patients have joint hypermobility syndromes.60 Causality is unclear.

  • While supine or seated, some patients appear well, others pasty pale.

  • Patients are unable to remain upright for long periods of time. Symptoms are similar to the prodrome of VVS.

  • BP is typically well maintained and may increase when upright in hyperadrenergic individuals. Prolonged laboratory tilt may provoke VVS.

  • Cognitive deficits and exercise intolerance are prominent complaints.61

  • Gastrointestinal symptoms include dysmotility issues.62

  • Young women may be underweight, and POTS must be differentiated from eating disorders, which can produce POTS-like OI in early stages.

  • Environmental heat reroutes blood to the skin and makes patients worse. Air-conditioning may be required and standing hot showers untenable.

  • Schoolwork may be impaired. Home schooling is common. Colleges are often accommodating because of adaptive scheduling and improved logistics.

  • A wide variety of pharmacologic therapies are recommended with variable effects including β blockade, α-1 agonists (midodrine), acetylcholinesterase inhibitors (pyridostigmine), and fludrocortisone acetate (Florinef). Treatment options are shown in Table 1.

  • Water ingestion is a useful, short-lived palliation.63 Effects are through TRPV4 receptors in the splanchnic vasculature.64 Sixteen ounces of water and waiting 20 to 30 minutes yields benefit for hours.

  • Salt and water loading can help but often require Spartan efforts.

  • Even when the cause is known (eg, NET deficiency) pharmacologic treatment is rarely curative. Most young people improve over time. In some, POTS persists.

Postural Syncope (VVS, Neurally Mediated Syncope, Neurocardiogenic Syncope, Acute OI)

Syncope (fainting) is defined as “complete loss of consciousness [and postural tone] due to transient global cerebral hypoperfusion characterized by rapid onset, short duration, and spontaneous complete recovery”65. This means that people lose consciousness and fall down, and it is caused by critically reduced blood flow (∼50%66) or oxygen supply to the brain. Other causes of abrupt loss of consciousness such as seizures have neither decreased ictal CBF67 nor typically hypotension. BP and CBF determinations during loss of consciousness are infrequently obtained during episodes outside of the laboratory. Apparent loss of consciousness without profoundly decreased cerebral oxygen delivery is not syncope. The lifetime incidence of VVS is ∼40%, half presenting during adolescence.6870 The most frequent age for first syncope is 15 years.68

What Causes Syncope?

The most common cause for syncope is hypotension. Conceivably, a transient ischemic attack could cause syncope, although this is infrequent. A separate form of cerebral hypoperfusion without hypotension known as cerebral syncope may produce syncope71 as can hypoxia from high-altitude exposure.72 The VVS response can be evoked in most people by sufficiently large orthostatic stressors or by hemorrhage.73 VVS may represent an evolutionary strategy to cope with excessive blood loss.74

Orthostatic Hypotension Can Cause Syncope

Syncope may be due to OH. This is ruled out by the 3-minute standing test.

Is It Cardiogenic or Reflex Syncope? What to Do With a First Faint

If syncope is not caused by OH syncope is partitioned among cardiogenic syncope, frequently due to cardiac arrhythmia or other cardiac disease and reflex or neurally mediated syncope. Cardiogenic syncope can be life-threatening and has a poor prognosis unless specific steps are taken to treat cardiac pathophysiology. Cardiogenic syncope is not OI because recumbency does not specifically produce improvement. Reflex syncope has a good prognosis.75 Reflex syncope includes VVS and situational syncope, including carotid sinus syncope,76 essentially unknown in pediatrics; deglutition,77 defecation,78 micturition,79 and cough80 syncopes rarely observed in the young; and hair grooming81 and adolescent stretch82 syncope, variants that are particular to adolescence. Fainting during exercise raises a red flag for cardiogenic syncope, and sport activity is curtailed until cardiac evaluation is complete. Nevertheless, the most common cause of exercise-related syncope in the young is VVS.83 Cardiogenic syncope, although not usually posturally related, cannot be automatically dismissed during a first faint. Therefore, the first and consequent episodes before cardiovascular evaluation should be treated as urgent. If fainting is subsequently found to be noncardiogenic, then urgency is reduced and simple maneuvers (discussed later) often suffice to deal acutely with the circumstance. The initial evaluation of a patient presenting with syncope comprises a detailed history, physical examination, including orthostatic BP measurements, and an electrocardiogram to look for QT prolongation, preexcitation, and arrhythmia. History is paramount. Historical details that point toward reflex syncope69 include a history of similar recurrent episodes, whether episode(s) occur exclusively when upright or with change in position; whether they are related to activity such as urination, defecation, deglutition, hair grooming, or stretch; whether there are predisposing factors such as fear, noxious stimuli, environmental heat, or immobilization; whether they follow exercise; and whether they are preceded by the prodrome of OI (eg, nausea, sweating pallor). A more gradual onset (many seconds to minutes) favors reflex syncope, as does a postdrome of pallor, fatigue, and confusion. History that favors an increased likelihood of cardiac syncope includes antecedent heart disease, family history of sudden death, known arrhythmia or arrhythmia risk such as long QT syndrome or preexcitation, an arrhythmogenic medication history, palpitations preceding the episode, and episodes that occur abruptly, during exercise, or when supine.

VVS = Postural Syncope or Emotional Syncope

Postural syncope and emotional stress syncope (eg, “blood phobia”) comprise VVS, which is the largest subgroup within reflex syncope.84 Regional or systemwide loss of sympathetic adrenergic vasoconstriction occurs in all VVS.85 Loss of consciousness is most often preceded by a prodrome of OI symptoms, particularly lightheadedness, nausea, sweating, weakness, and visual disturbance (eg, “blackout,” scotomata). VVS patients often have CNS residua after recovery including headache, disorientation, occasional amnesia for the episode, and severe fatigue.86 The “postdrome” is more characteristic of VVS than of (brief) cardiogenic syncope. It is best to rest for the remainder of the day because subsequent VVS can be most easily induced on the day of faint.86 Until recently, VVS was thought to be caused by C-fiber afferents activated by a hypercontractile underfilled heart akin to the Bezold-Jarisch chemoreflex.87 There is evidence to the contrary. Thus, any such stimulus could be short-lived because baroreceptors would be immediately unloaded88; few afferent nerves were excited in the original hemorrhaged cat model89; VVS can occur in a transplant recipient with denervated ventricles90; and the heart before syncope is neither empty nor hypercontractile.91 To date, the pathophysiology of simple faint remains elusive.92

Postural VVS

Postural syncope is acute OI. Approximately two-thirds of patients are female. Teenage boys tend to be tall, thin, and rapidly growing.84

The most common variant of postural faint occurs episodically in otherwise healthy young patients. Between episodes most VVS fainters are well. However, at times episodes of syncope or presyncope (aborted syncope) may become chronic, as in some patients with the chronic fatigue syndrome.93

In classic form, postural faint often comprises 3 upright stages (Fig 5), which closely emulate the circulatory changes that occur during progressive hemorrhage.

FIGURE 5.

FIGURE 5

A representative VVS patient’s data during a tilt test. HR (top panel) increases until late into the course when it falls abruptly. Mean arterial pressure (MAP, bottom panel) initially stabilizes, then slowly decreases, and finally falls abruptly along with HR. SNA, sympathetic nervous activity; TPR, total peripheral resistance.

Stage 1. After IOH, hemodynamic equilibrium is reestablished. BP stabilizes, and HR increases. Restabilization distinguishes VVS from true OH in which BP falls early and remains low. BP and sympathetic activity are often oscillatory with a 10-second period. Sympathetic activity, compensatory vasoconstriction, and HR are typically increased compared with healthy subjects.94 Oscillations, often referred to as Mayer waves95, represent the delay between sensing and compensating for a change in BP.96 This requires intact autonomic reflexes, which are enhanced during central blood volume unloading during standing.

Stage 2. Thereafter, BP slowly declines as HR reflexively increases. The decrease in BP is attributed to a reduction in CO97 despite increased vasoconstriction and sympathetic activity.98 Prodromal OI symptoms (presyncope) often begin at this point. When combined with tachycardia, a diagnosis of POTS may be entertained in the laboratory setting. However, the HR is rarely >120 beats per minute, and a history of episodic faints interspersed with periods free of OI symptoms distinguishes postural syncope from POTS, in which OI is chronic. Medical history is paramount. Hyperpnea and hypocapnia are also observed and contribute to reduced CBFv.25

Recent explanations offered for the early phases of postural VVS include reduced tyrosine hydroxylase and norepinephrine synthesis in patients with low resting BP, excess NET,99 or selective deficit of splanchnic blood vessel vasoconstriction.49 Postural VVS is uncommon in patients with vasoconstricted hyperadrenergic POTS.

Most POTS patients have day-to-day symptoms but do not faint, whereas most fainters faint episodically but do not have daily symptoms. This distinction has blurred over time; some POTS patients have fainted, typically not concurrently with POTS, and some fainters have daily symptoms that are recognizably presyncopal. Nevertheless, loss of consciousness in POTS is relatively uncommon outside of the laboratory.

Stage 3. Brain blood flow, vasoconstriction, BP, and HR fall precipitously, in that order,100 causing loss of consciousness. Recent data suggest loss of cardiovagal and sympathetic baroreflex integrity and loss of cerebral autoregulation with entrainment by hyperpnea driven pulmonary reflexes.24,101

In some patients, an abrupt fall in BP and HR is absent (no stage 3). Instead, BP falls steadily while HR continues to rise. This is often called vasodepressor syncope, which in our experience is caused by decreased peripheral resistance and maintained CO. In still other patients, the slow fall in BP is abbreviated or absent (no stage 2, Fig 6) giving rise to convulsive syncope.102 Episodes occur abruptly, without warning (no prodrome) and in association with asystole or severe bradycardia. Brief, clonic jerks occur with convulsive syncope but generalized tonic-clonic seizures, typical of epilepsy, are uncommon. EEG shows slowing rather than spikes and findings resolve once supine. Asystole also occurs with phobic VVS. Recently, studies of adults aged >40 years show improvement in asystolic or severely bradycardic VVS with cardiac pacing.103 Other forms of VVS do not. There is no controlled data for the pediatric age group. In adults, tilt table induced asystole is unrelated to real-world asystole in older patients28; this has not been ascertained in younger patients.

FIGURE 6.

FIGURE 6

Asystolic postural VVS during a tilt test. HR (electrocardiogram, top panel) rapidly transits to asystole from a preceding sinus tachycardia. BP (bottom panel) falls in concert. There was no prodrome, although careful scrutiny shows a small decrease in BP before asystole supervenes.

How Can VVS Be Treated(Table 1)?

  • VVS is not deadly unless one is in harm’s way.

  • To date, no single pharmacologic intervention has proven effective above the placebo effect in large clinical trials.104,105 Placebo exerts 30% to 40% benefit in these studies. Treatment options are shown in Table 1.

  • Iron and even ferritin deficiency aggravates VVS.106

  • Trained athletes have increased risk of VVS compared with untrained persons.107

  • Salt and water supplementation can be helpful, but a large amount of salt is needed108.

  • Currently, compensatory physical maneuvers (countermeasures) are recommended treatment.5

  • The fainting prodrome must be recognized for countermeasures to be effective. First faints are rarely countered because patients do not understand what’s happening.

  • Countermeasures: immediate lying down or squatting cause postural VVS to cease; with prolonged prodrome counterpressure such as leg crossing, buttocks clenching, or fist clenching may be effective.109111

  • Once supine, the patient should not immediately stand. Instead, I suggest a 16-oz bottle of water and remaining supine for >20 minutes after the episode.

  • If there is no prodrome or if there is abrupt onset with injury, consider asystolic vasovagal faint or an arrhythmia and evaluate by loop recording electrocardiography.112,113 Twenty-four hour Holter monitoring is inadequate for arrhythmia determination.84

  • If total loss of consciousness is not transient, then it is not a faint; it is coma. VVS is <2 minutes of total loss of consciousness, as a matter of consensus. Rarely, fainting promotes an underlying seizure disorder via cerebral ischemia.

  • Very frequent or extremely prolonged syncope can point to psychogenic syncope or conversion responses. These are easily distinguished from true syncope in the laboratory because there is no hypotension or reduced CBF. However, attacks may be real to the patient. Some patients may have had bona fide VVS interspersed with more frequent psychogenic episodes as learned or conditioned responses. One school of thought suggests that such patients actually experience the symptoms of true VVS without the signs.

Postural Hyperpnea

Standing causes an increase in tidal volume, which is accentuated by increased central blood volume unloading.114 Marked involuntary hyperpneic hypocapnia precedes VVS in association with hypotension and in 50% of POTS patients without hypotension25,26,115 and reduces CBF. CO2 administration relieves hyperventilation, but paper bag rebreathing promotes hypoxia.116

Postural hyperpnea occurs without POTS where it has been regarded as part of a psychogenic hyperventilation syndrome.117 In our hands, postural hyperpnea occurs during normoxic aerobic physical activities, particularly in athletic young women in whom it can be associated with variable changes in BP, increased HR, vasoconstriction, sympathetic activation, and decreased CO, CO2 and CBF as a result of hypocapnia. It is provoked by upright tilt and relieved by administering CO2. Hypocapnia, sympathetic activation, and anxiety occur in order. The patient experiences marked dyspnea, chest pain, limb tingling, and numbness. Cardiopulmonary evaluations are normal.

Summary

  • OI is defined by symptoms and signs when upright relieved by recumbence.

  • OH is a form of OI, but neurogenic OH is rare in childhood

  • Initial OH is a common form of OI in the young.

  • Postural tachycardia syndrome is a form of chronic OI that can result from a partial denervated circulatory system, a hyperadrenergic state, or chronic bed rest.

  • It is essential to distinguish reflex syncope from cardiogenic syncope.

  • Postural VVS is the most common form of OI, occurring ≥1 times in 40% of the populace throughout life. The most common age of onset is age 15 years.

  • Physical countermeasures can defend against OI. Lying down aborts VVS. Do not constrain a VVS patient in the upright position.

  • Postural hyperpnea may be a separate OI syndrome distinct from anxiety disorders.

Future research

OI is common at all ages. Neither VVS nor POTS is completely understood in terms of molecular and genetic/epigenetic mechanisms. However, progress has been made recently in the study of neurovascular signaling molecules and in potential related genetic and epigenetic disorders. In addition to determining basic mechanisms, it will be important to define physiologic correlates of common symptoms, including postural lightheadedness, exercise intolerance, and memory and concentration problems when upright.

Glossary

ANS

autonomic nervous system

BP

blood pressure

CBF

cerebral blood flow

CBFv

cerebral blood flow velocity

CNS

central nervous system

CO

cardiac output

HR

heart rate

IOH

initial orthostatic hypotension

NET

norepinephrine transporter

NOH

neurogenic orthostatic hypotension

OH

orthostatic hypotension

OI

orthostatic intolerance

POTS

postural tachycardia syndrome

VVS

vasovagal syncope

Footnotes

Dr Stewart has made a substantial contribution to conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content; he gave final approval of the version to be published.

FINANCIAL DISCLOSURE: The author has indicated he has no financial relationships relevant to this article to disclose.

FUNDING: This work was supported by the National Heart, Lung, and Blood Institute (grants RO1-HL074873 and RO1-HL087803). Funded by the National Institutes of Health (NIH).

References

  • 1.Rowell LB. Human Cardiovascular Control. New York, NY: Oxford University Press; 1993 [Google Scholar]
  • 2.Miller JD, Pegelow DF, Jacques AJ, Dempsey JA. Skeletal muscle pump versus respiratory muscle pump: modulation of venous return from the locomotor limb in humans. J Physiol. 2005;563(pt 3):925–943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wang Y, Marshall RJ, Shepherd JT. The effect of changes in posture and of graded exercise on stroke volume in man. J Clin Invest. 1960;39(7):1051–1061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Thijs RD, Wieling W, van den Aardweg JG, van Dijk JG. Respiratory countermaneuvers in autonomic failure. Neurology. 2007;69(6):582–585 [DOI] [PubMed] [Google Scholar]
  • 5.van Dijk N, de Bruin IG, Gisolf J, et al. Hemodynamic effects of leg crossing and skeletal muscle tensing during free standing in patients with vasovagal syncope. J Appl Physiol. 2005;98(2):584–590 [DOI] [PubMed] [Google Scholar]
  • 6.Loutzenhiser R, Bidani A, Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res. 2002;90(12):1316–1324 [DOI] [PubMed] [Google Scholar]
  • 7.Shipley RD, Kim SJ, Muller-Delp JM. Time course of flow-induced vasodilation in skeletal muscle: contributions of dilator and constrictor mechanisms. Am J Physiol Heart Circ Physiol. 2005;288(4):H1499–H1507 [DOI] [PubMed] [Google Scholar]
  • 8.Von Euler US. Identification of the sympathomimetic ergone in adrenergic nerves of cattle (sympathin N) with levo-noradrenaline. Acta Physiol Scand. 1948;16:63–74 [Google Scholar]
  • 9.Macarthur H, Wilken GH, Westfall TC, Kolo LL. Neuronal and non-neuronal modulation of sympathetic neurovascular transmission. Acta Physiol (Oxf). 2011;203(1):37–45 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Raczak G, La Rovere MT, Mortara A, et al. Arterial baroreflex modulation of heart rate in patients early after heart transplantation: lack of parasympathetic reinnervation. J Heart Lung Transplant. 1999;18(5):399–406 [DOI] [PubMed] [Google Scholar]
  • 11.Brack KE, Coote JH, Ng GA. Vagus nerve stimulation inhibits the increase in Ca2+ transient and left ventricular force caused by sympathetic nerve stimulation but has no direct effects alone—epicardial Ca2+ fluorescence studies using fura-2 AM in the isolated innervated beating rabbit heart. Exp Physiol. 2010;95(1):80–92 [DOI] [PubMed] [Google Scholar]
  • 12.Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61(1):62–97 [DOI] [PubMed] [Google Scholar]
  • 13.Aviado DM, Jr, Schmidt CF. Reflexes from stretch receptors in blood vessels, heart and lungs. Physiol Rev. 1955;35(2):247–300 [DOI] [PubMed] [Google Scholar]
  • 14.Rothe CF. Venous system: physiology of the capacitance vessels. In: Shepherd JT, Abboud FM, Geiger SR, Handbook of Physiology: The Cardiovascular System Peripheral Circulation, vol. III. Washington, DC: American Physiologic Society; 1983:397–452 [Google Scholar]
  • 15.Sheriff DD, Nådland IH, Toska K. Role of sympathetic responses on the hemodynamic consequences of rapid changes in posture in humans. J Appl Physiol. 2010;108(3):523–532 [DOI] [PubMed] [Google Scholar]
  • 16.Wieling W, Krediet CT, van Dijk N, Linzer M, Tschakovsky ME. Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond). 2007;112(3):157–165 [DOI] [PubMed] [Google Scholar]
  • 17.Hill L. The influences of the force of gravity on the circulation of the blood. J Physiol. 1951;18:15–53 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87(2):198–210 [DOI] [PubMed] [Google Scholar]
  • 19.Carey BJ, Manktelow BN, Panerai RB, Potter JF. Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope. Circulation. 2001;104(8):898–902 [DOI] [PubMed] [Google Scholar]
  • 20.Robertson D. The epidemic of orthostatic tachycardia and orthostatic intolerance. Am J Med Sci. 1999;317(2):75–77 [DOI] [PubMed] [Google Scholar]
  • 21.Low PA, Opfer-Gehrking TL, McPhee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc. 1995;70(7):617–622 [DOI] [PubMed] [Google Scholar]
  • 22.Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959;39(2):183–238 [DOI] [PubMed] [Google Scholar]
  • 23.Ocon AJ, Medow MS, Taneja I, Clarke D, Stewart JM. Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2009;297(2):H664–H673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ocon AJ, Kulesa J, Clarke D, Taneja I, Medow MS, Stewart JM. Increased phase synchronization and decreased cerebral autoregulation during fainting in the young. Am J Physiol Heart Circ Physiol. 2009;297(6):H2084–H2095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lagi A, Cencetti S, Corsoni V, Georgiadis D, Bacalli S. Cerebral vasoconstriction in vasovagal syncope: any link with symptoms? A transcranial Doppler study. Circulation. 2001;104(22):2694–2698 [DOI] [PubMed] [Google Scholar]
  • 26.Stewart JM, Medow MS, Cherniack NS, Natelson BH. Postural hypocapnic hyperventilation is associated with enhanced peripheral vasoconstriction in postural tachycardia syndrome with normal supine blood flow. Am J Physiol Heart Circ Physiol. 2006;291(2):H904–H913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol. 2006;100(3):1059–1064 [DOI] [PubMed] [Google Scholar]
  • 28.Brignole M, Sutton R, Menozzi C, et al. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group . Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J. 2006;27(18):2232–2239 [DOI] [PubMed] [Google Scholar]
  • 29.Claydon VE, Hainsworth R. Increased postural sway in control subjects with poor orthostatic tolerance. J Am Coll Cardiol. 2005;46(7):1309–1313 [DOI] [PubMed] [Google Scholar]
  • 30.Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1(8494):1352–1355 [DOI] [PubMed] [Google Scholar]
  • 31.Plash WB, Diedrich A, Biaggioni I, et al. Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics. Clin Sci (Lond). 2013;124(2):109–114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Taneja I, Moran C, Medow MS, Glover JL, Montgomery LD, Stewart JM. Differential effects of lower body negative pressure and upright tilt on splanchnic blood volume. Am J Physiol Heart Circ Physiol. 2007;292(3):H1420–H1426 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70(4):963–985 [DOI] [PubMed] [Google Scholar]
  • 34.Lambert E, Eikelis N, Esler M, et al. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol. 2008;1(2):103–109 [DOI] [PubMed] [Google Scholar]
  • 35.Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72 [DOI] [PubMed] [Google Scholar]
  • 36.Shibao C, Okamoto L, Biaggioni I. Pharmacotherapy of autonomic failure. Pharmacol Ther. 2012;134(3):279–286 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS, CHS Collaborative Research Group . Orthostatic hypotension in older adults. The Cardiovascular Health Study. Hypertension. 1992;19(6 pt 1):508–519 [DOI] [PubMed] [Google Scholar]
  • 38.Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43(1):132–137 [DOI] [PubMed] [Google Scholar]
  • 39.Furlan R, Jacob G, Snell M, et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation. 1998;98(20):2154–2159 [DOI] [PubMed] [Google Scholar]
  • 40.Singer W, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA. Postural tachycardia in children and adolescents: what is abnormal? J Pediatr. 2012;160(2):222–226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120(9):725–734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Perry WL, Reinert H. The action of cardiac glycosides on autonomic ganglia. Br Pharmacol Chemother. 1954;9(3):324–328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005;111(21):2734–2740 [DOI] [PubMed] [Google Scholar]
  • 44.McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace. 2011;13(3):427–430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Femenía F, Baranchuk A, Morillo CA. Inappropriate sinus tachycardia: current therapeutic options. Cardiol Rev. 2012;20(1):8–14 [DOI] [PubMed] [Google Scholar]
  • 46.Jacob G, Costa F, Shannon JR, et al. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343(14):1008–1014 [DOI] [PubMed] [Google Scholar]
  • 47.Stewart JM. Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects. Circulation. 2002;105(19):2274–2281 [DOI] [PubMed] [Google Scholar]
  • 48.Stewart JM, Weldon A. Reflex vascular defects in the orthostatic tachycardia syndrome of adolescents. J Appl Physiol. 2001;90(6):2025–2032 [DOI] [PubMed] [Google Scholar]
  • 49.Stewart JM, Medow MS, Glover JL, Montgomery LD. Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2006;290(2):H665–H673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003;53(6):752–758 [DOI] [PubMed] [Google Scholar]
  • 51.Bonyhay I, Freeman R. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation. 2004;110(20):3193–3198 [DOI] [PubMed] [Google Scholar]
  • 52.Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342(8):541–549 [DOI] [PubMed] [Google Scholar]
  • 53.Stewart JM, Ocon AJ, Clarke D, Taneja I, Medow MS. Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome. Hypertension. 2009;53(5):767–774 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Convertino VA, Bloomfield SA, Greenleaf JE. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc. 1997;29(2):187–190 [DOI] [PubMed] [Google Scholar]
  • 55.Blomqvist CG, Buckey JC, Gaffney FA, Lane LD, Levine BD, Watenpaugh DE. Mechanisms of post-flight orthostatic intolerance. J Gravit Physiol. 1994;1(1):122–124 [PubMed] [Google Scholar]
  • 56.Meck JV, Dreyer SA, Warren LE. Long-duration head-down bed rest: project overview, vital signs, and fluid balance. Aviat Space Environ Med. 2009;80(5 Suppl):A1–A8 [DOI] [PubMed] [Google Scholar]
  • 57.Arbeille P, Kerbeci P, Mattar L, Shoemaker JK, Hughson R. Insufficient flow reduction during LBNP in both splanchnic and lower limb areas is associated with orthostatic intolerance after bedrest. Am J Physiol Heart Circ Physiol. 2008;295(5):H1846–H1854 [DOI] [PubMed] [Google Scholar]
  • 58.Fu Q, Vangundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension. 2011;58(2):167–175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Parsaik A, Allison TG, Singer W, et al. Deconditioning in patients with orthostatic intolerance. Neurology. 2012;79(14):1435–1439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003;115(1):33–40 [DOI] [PubMed] [Google Scholar]
  • 61.Stewart JM, Medow MS, Messer ZR, Baugham IL, Terilli C, Ocon AJ. Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2012;302(5):H1185–H1194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ojha A, Chelimsky TC, Chelimsky G. Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr. 2011;158(1):20–23 [DOI] [PubMed] [Google Scholar]
  • 63.Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D. A potent pressor response elicited by drinking water. Lancet. 1999;353(9154):723. [DOI] [PubMed] [Google Scholar]
  • 64.McHugh J, Keller NR, Appalsamy M, et al. Portal osmopressor mechanism linked to transient receptor potential vanilloid 4 and blood pressure control. Hypertension. 2010;55(6):1438–1443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Gowers WR. A lecture on vagal and vasovagal attacks. Lancet. 1907;169(4371):1551–1554 [Google Scholar]
  • 66.Van Lieshout JJ, Wieling W, Karemaker JM, Secher NH. Syncope, cerebral perfusion, and oxygenation. J Appl Physiol. 2003;94(3):833–848 [DOI] [PubMed] [Google Scholar]
  • 67.Duncan R. Epilepsy, cerebral blood flow, and cerebral metabolic rate. Cerebrovasc Brain Metab Rev. 1992;4(2):105–121 [PubMed] [Google Scholar]
  • 68.Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91:(8)1006–1008, A8 [DOI] [PubMed]
  • 69.Moya A, Sutton R, Ammirati F, et al. Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC) European Heart Rhythm Association (EHRA) Heart Failure Association (HFA) Heart Rhythm Society (HRS) . Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30(21):2631–2671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Serletis A, Rose S, Sheldon AG, Sheldon RS. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J. 2006;27(16):1965–1970 [DOI] [PubMed] [Google Scholar]
  • 71.Rodríguez-Núñez A, Fernández-Cebrián S, Pérez-Muñuzuri A, Martinón-Torres F, Eirís-Puñal J, Martinón-Sánchez JM. Cerebral syncope in children. J Pediatr. 2000;136(4):542–544 [DOI] [PubMed] [Google Scholar]
  • 72.Nicholas R, O’Meara PD, Calonge N. Is syncope related to moderate altitude exposure? JAMA. 1992;268(7):904–906 [PubMed] [Google Scholar]
  • 73.Barcroft H, McMichael JE, Scarpey-Schafer EP. Posthaemorrhagic fainting. Study by cardiac output and forearm flow. Lancet. 1944;243(6294):489–491 [Google Scholar]
  • 74.Diehl RR. Vasovagal syncope and Darwinian fitness. Clin Auton Res. 2005;15(2):126–129 [DOI] [PubMed] [Google Scholar]
  • 75.Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878–885 [DOI] [PubMed] [Google Scholar]
  • 76.Brignole M, Menozzi C. The natural history of carotid sinus syncope and the effect of cardiac pacing. Europace. 2011;13(4):462–464 [DOI] [PubMed] [Google Scholar]
  • 77.Engelhardt W, Kotlarek F, von Bernuth G. Deglutition syncope in childhood with complete atrioventricular block. Am J Cardiol. 1986;58(11):1113–1114 [DOI] [PubMed] [Google Scholar]
  • 78.Kapoor WN, Peterson J, Karpf M. Defecation syncope. A symptom with multiple etiologies. Arch Intern Med. 1986;146(12):2377–2379 [DOI] [PubMed] [Google Scholar]
  • 79.Bae MH, Kang JK, Kim NY, et al. Clinical characteristics of defecation and micturition syncope compared with common vasovagal syncope. Pacing Clin Electrophysiol. 2012;35(3):341–347 [DOI] [PubMed] [Google Scholar]
  • 80.Benditt DG, Samniah N, Pham S, et al. Effect of cough on heart rate and blood pressure in patients with “cough syncope.” Heart Rhythm. 2005;2(8):807–813 [DOI] [PubMed] [Google Scholar]
  • 81.Evans WN, Acherman R, Kip K, Restrepo H. Hair-grooming syncope in children. Clin Pediatr (Phila). 2009;48(8):834–836 [DOI] [PubMed] [Google Scholar]
  • 82.Sarrigiannis PG, Randall M, Kandler RH, Grunewald RA, Harkness K, Reuber M. Stretch syncope: reflex vasodepressor faints easily mistaken for epilepsy. Epilepsy Behav. 2011;20(3):450–453 [DOI] [PubMed] [Google Scholar]
  • 83.Colivicchi F, Ammirati F, Biffi A, Verdile L, Pelliccia A, Santini M. Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J. 2002;23(14):1125–1130 [DOI] [PubMed] [Google Scholar]
  • 84.The European Society of Cardiology Guidelines for the diagnosis and management of syncope reviewed by Angel Moya, MD, FESC, Chair of the Guideline Taskforce with J. Taylor, MPhil. Eur Heart J. 2009;30(21):2539–2540 [DOI] [PubMed] [Google Scholar]
  • 85.Sharpey-Schafer EP. Syncope. BMJ. 1956;1(4965):506–509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Wieling W, Thijs RD, van Dijk N, Wilde AA, Benditt DG, van Dijk JG. Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. 2009;132(pt 10):2630–2642 [DOI] [PubMed] [Google Scholar]
  • 87.Aviado DM, Guevara Aviado D. The Bezold-Jarisch reflex. A historical perspective of cardiopulmonary reflexes. Ann N Y Acad Sci. 2001;940:48–58 [PubMed] [Google Scholar]
  • 88.Hainsworth R. Syncope: what is the trigger? Heart. 2003;89(2):123–124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Oberg B, Thorén P. Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat. A possible cause of the vaso-vagal reaction. Acta Physiol Scand. 1972;85(2):164–173 [DOI] [PubMed] [Google Scholar]
  • 90.Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG. Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient. N Engl J Med. 1990;322(9):602–604 [DOI] [PubMed] [Google Scholar]
  • 91.Liu JE, Hahn RT, Stein KM, et al. Left ventricular geometry and function preceding neurally mediated syncope. Circulation. 2000;101(7):777–783 [DOI] [PubMed] [Google Scholar]
  • 92.Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102(23):2898–2906 [DOI] [PubMed] [Google Scholar]
  • 93.Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med. 1998;105(3A):15S–21S [DOI] [PubMed] [Google Scholar]
  • 94.Taneja I, Medow MS, Glover JL, Raghunath NK, Stewart JM. Increased vasoconstriction predisposes to hyperpnea and postural faint. Am J Physiol Heart Circ Physiol. 2008;295(1):H372–H381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Julien C. The enigma of Mayer waves: Facts and models. Cardiovasc Res. 2006;70(1):12–21 [DOI] [PubMed] [Google Scholar]
  • 96.Hammer PE, Saul JP. Resonance in a mathematical model of baroreflex control: arterial blood pressure waves accompanying postural stress. Am J Physiol Regul Integr Comp Physiol. 2005;288(6):R1637–R1648 [DOI] [PubMed] [Google Scholar]
  • 97.Verheyden B, Liu J, van Dijk N, et al. Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope. Heart Rhythm. 2008;5(12):1695–1701 [DOI] [PubMed] [Google Scholar]
  • 98.Cooke WH, Rickards CA, Ryan KL, Kuusela TA, Convertino VA. Muscle sympathetic nerve activity during intense lower body negative pressure to presyncope in humans. J Physiol. 2009;587(pt 20):4987–4999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Vaddadi G, Guo L, Esler M, et al. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol. 2011;4(5):711–718 [DOI] [PubMed] [Google Scholar]
  • 100.Dan D, Hoag JB, Ellenbogen KA, Wood MA, Eckberg DL, Gilligan DM. Cerebral blood flow velocity declines before arterial pressure in patients with orthostatic vasovagal presyncope. J Am Coll Cardiol. 2002;39(6):1039–1045 [DOI] [PubMed] [Google Scholar]
  • 101.Ocon AJ, Medow MS, Taneja I, Stewart JM. Respiration drives phase synchronization between blood pressure and RR interval following loss of cardiovagal baroreflex during vasovagal syncope. Am J Physiol Heart Circ Physiol. 2011;300(2):H527–H540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Grubb BP, Gerard G, Roush K, et al. Differentiation of convulsive syncope and epilepsy with head-up tilt testing [see comments]. Ann Intern Med. 1991;115(11):871–876 [DOI] [PubMed] [Google Scholar]
  • 103.Brignole M, Menozzi C, Moya A, et al. International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators . Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012;125(21):2566–2571 [DOI] [PubMed] [Google Scholar]
  • 104.Sheldon RS, Amuah JE, Connolly SJ, et al. Prevention of Syncope Trial . Effect of metoprolol on quality of life in the Prevention of Syncope Trial. J Cardiovasc Electrophysiol. 2009;20(10):1083–1088 [DOI] [PubMed] [Google Scholar]
  • 105.Raj SR, Rose S, Ritchie D, Sheldon RS, POST II Investigators . The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J. 2006;151(6):1186–1187, e11–e17 [DOI] [PubMed] [Google Scholar]
  • 106.Jarjour IT, Jarjour LK. Low iron storage in children and adolescents with neurally mediated syncope. J Pediatr. 2008;153(1):40–44 [DOI] [PubMed] [Google Scholar]
  • 107.Levine BD, Buckey JC, Fritsch JM, et al. Physical fitness and cardiovascular regulation: mechanisms of orthostatic intolerance. J Appl Physiol. 1991;70(1):112–122 [DOI] [PubMed] [Google Scholar]
  • 108.Claydon VE, Hainsworth R. Salt supplementation improves orthostatic cerebral and peripheral vascular control in patients with syncope. Hypertension. 2004;43(4):809–813 [DOI] [PubMed] [Google Scholar]
  • 109.Romme JJ, Reitsma JB, Go-Schön IK, et al. Prospective evaluation of non-pharmacological treatment in vasovagal syncope. Europace. 2010;12(4):567–573 [DOI] [PubMed] [Google Scholar]
  • 110.van Dijk N, Quartieri F, Blanc JJ, et al. PC-Trial Investigators . Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol. 2006;48(8):1652–1657 [DOI] [PubMed] [Google Scholar]
  • 111.Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002;40(11):2053–2059 [DOI] [PubMed] [Google Scholar]
  • 112.Rossano J, Bloemers B, Sreeram N, Balaji S, Shah MJ. Efficacy of implantable loop recorders in establishing symptom-rhythm correlation in young patients with syncope and palpitations. Pediatrics. 2003;112(3 pt 1):e228–e233 [DOI] [PubMed] [Google Scholar]
  • 113.Frangini PA, Cecchin F, Jordao L, et al. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008;31(3):338–343 [DOI] [PubMed] [Google Scholar]
  • 114.Matalon SV, Farhi LE. Cardiopulmonary readjustments in passive tilt. J Appl Physiol. 1979;47(3):503–507 [DOI] [PubMed] [Google Scholar]
  • 115.Novak V, Spies JM, Novak P, McPhee BR, Rummans TA, Low PA. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke. 1998;29(9):1876–1881 [DOI] [PubMed] [Google Scholar]
  • 116.Callaham M. Hypoxic hazards of traditional paper bag rebreathing in hyperventilating patients. Ann Emerg Med. 1989;18(6):622–628 [DOI] [PubMed] [Google Scholar]
  • 117.Malmberg LP, Tamminen K, Sovijärvi AR. Orthostatic increase of respiratory gas exchange in hyperventilation syndrome. Thorax. 2000;55(4):295–301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Kaufmann H. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clin Auton Res. 2008;18(suppl 1):19–24 [DOI] [PubMed] [Google Scholar]
  • 119.Tanaka H, Yamaguchi H, Mino M. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance. Clin Auton Res. 1996;6(4):189–193 [DOI] [PubMed] [Google Scholar]

Articles from Pediatrics are provided here courtesy of American Academy of Pediatrics

RESOURCES